CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024

Award

Buyers

Value

£46,600,000

Classifications

  • Pharmaceutical products

Tags

  • award

Submission Deadline

8 months ago

Published

5 months ago

Description

Project Title: NHS National Framework for Tocilizumab - March 2024

Offer reference number: CM/PHR/23/5702

CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

Katie Noonan

[email protected]

Timeline complete

Publish
Bid
Evaluate
Award
Complete